SCHEMBL20801640

SCHEMBL20801640

CN(C)CC(=O)NCCNCCNCCNCCNCCNC(=O)CN(C)C

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
ALDH1A1 P00352 2/20 0.40
HTT P42858 1/20 0.40
DNM1 Q05193 2/20 0.37
USP2 O75604 1/20 0.34
TSHR P16473 1/20 0.34
CA3 P07451 1/20 0.34
CA5A P35218 1/20 0.34
CA5B Q9Y2D0 1/20 0.34
PAOX Q6QHF9 1/20 0.34
KDM4E B2RXH2 3/20 0.33
MAPT P10636 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
KDM7A Q6ZMT4 1/20 0.32
PHF8 Q9UPP1 1/20 0.32
KDM2A Q9Y2K7 1/20 0.32
PARP1 P09874 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL435406 0.85 DNM1 (0.34) MEN1KMT2AALDH1A1HTTDNM1
SCHEMBL13997591 0.84 PRMT3 (0.39) MEN1KMT2AALDH1A1DNM1USP2
SCHEMBL22382538 0.84 DNM1 (0.36) MEN1KMT2AALDH1A1DNM1USP2
SCHEMBL8227224 0.84 KDM4E (0.46) MEN1KMT2AALDH1A1DNM1USP2
SCHEMBL1827225 0.83 MEN1 (0.54) MEN1KMT2AALDH1A1DNM1TSHR
SCHEMBL8741153 0.83 MEN1 (0.48) MEN1KMT2AALDH1A1DNM1TSHR
SCHEMBL1569983 0.81 DNM1 (0.40) MEN1KMT2AALDH1A1DNM1USP2
SCHEMBL2127728 0.81 MCL1 (0.48) MEN1KMT2ADNM1TSHRMAPT
SCHEMBL1569981 0.81 DNM1 (0.37) MEN1KMT2AALDH1A1DNM1MAPT
SCHEMBL8956453 0.81 HDAC1 (0.40) MEN1KMT2ADNM1MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10385013-B2 Micro/nano materials, products obtained by covalently modifying surface of micro/nano materials with hydrophilic materials, and method for making same CHONGQING BOLANYING (BLY) BIOTECHNOLOGY CO., LTD. (CN) 2019-08-20 US disclosed
US-20190077746-A1 MICRO/NANO MATERIALS, PRODUCTS OBTAINED BY COVALENTLY MODIFYING SURFACE OF MICRO/NANO MATERIALS WITH HYDROPHILIC MATERIALS, AND METHOD FOR MAKING SAME CHONGQING BOLANYING (BLY) BIOTECHNOLOGY CO., LTD. (CN) 2019-03-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190077746-A1 MICRO/NANO MATERIALS, PRODUCTS OBTAINED BY COVALENTLY MODIFYING SURFACE OF MICRO/NANO MATERIALS WITH HYDROPHILIC MATERIALS, AND METHOD FOR MAKING SAME PHOSPHO1, PTMS, PAM MEN1 740/4885KMT2A 595/4885ALDH1A1 1407/4885
US-10385013-B2 Micro/nano materials, products obtained by covalently modifying surface of micro/nano materials with hydrophilic materials, and method for making same PHOSPHO1, PTMS, PAM MEN1 740/4885KMT2A 595/4885ALDH1A1 1407/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.